Are direct oral anticoagulants an economically attractive alternative to low molecular weight heparins in lung cancer associated venous thromboembolism management?

Are direct oral anticoagulants an economically attractive alternative to low molecular weight heparins in lung cancer associated venous thromboembolism management?. Howlett, Jennifer; Benzenine, Eric; Fagnoni, Philippe; Quantin, Catherine. Journal of Thrombosis and Thrombolysis. 2020; : . doi:10.1007/s11239-020-02047-1
Article